Table 5.
Kava and its components in cancer prevention.
Components | Cancer Type | Mechanism | Model | Reference |
---|---|---|---|---|
Kava | Lung cancer | Reduction in NNK induced DNA damage | A/J mice | [107] |
Kavalactone-rich fraction | Lung cancer | Reduction in NNK induced DNA damage | A/J mice | [108] |
Prostate cancer | Inhibition of angiogenesis and cell proliferation genes and upregulation of antitumor genes, immunity, muscle/neuro, and metabolism-related genes | Male C57BL/6J and female C57BL/6-Tg TRAMP 8247Ng/J mice | [116] | |
Nonpolar extract | Colon cancer | Reduction in precancerous lesions | Rat | [115] |
DHM | Lung cancer | Reduction in NNK induced DNA damage and NNAL detoxification | A/J mice | [33,109,111] |
lung cancer | Reduction in NNK induced DNA damage | C57BL/6 Female Mice | [110] | |
Flavokavain A | Urothelial cancer | Induction of apoptosis | UPII-SV40T mice | [113] |
Prostate cancer | Inhibition of proliferation and induction of apoptosis | Female hemizygous C57BL/TGN TRAMP mice and male C57BL/6 mice | [114] |